Share Twitter LinkedIn Facebook Email Aziz Nazha, MD of @CleClinicMD discusses a personalized prediction model to risk stratify patients with AML.
Transforming AML Treatment: The Breakthrough Precision and Speed of Dr. Gabriel Mannis, MD on the Notable Platform Acute Myelogenous Leukemia 1 Min Read
Molecular Changes and Patient Stratification – Parrish Phimes, MD Acute Myelogenous Leukemia 2 Mins Read
